Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study was to determine whether ADT started before or after
sipuleucel-T led to a better immune system response. This study also evaluated the safety of
sipuleucel-T and ADT treatment, immune system responses over time, the characteristics of
sipuleucel-T, and changes in prostate specific antigen (PSA) values over time.